Nivolumab in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck: A Tertiary Cancer Center Experience

Background  Immunotherapy is a proven therapeutic option in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) after platinum therapy. At present, there are no published Indian data regarding administration of nivolumab in this setting. Aim  The aim of this study is to retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Pareek, Ananya, Patel, Apurva A., Kumar, Mukesh, Kuttikat, Philip G., Annadanam, Harshavardhan, Pendse, Shantanu, Mohammed, Naseer, Panchal, Harsha P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273311/
https://www.ncbi.nlm.nih.gov/pubmed/35833038
http://dx.doi.org/10.1055/s-0041-1733317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273311/
https://www.ncbi.nlm.nih.gov/pubmed/35833038
http://dx.doi.org/10.1055/s-0041-1733317

Ejemplares similares